As if 2020 couldn’t get any more dramatic for investors, President Trump and his wife contracting the deadly illness has injected a fresh dose of uncertainty into the U.S. stock market.
President Donald Trump, who recently tested positive for the coronavirus, has been given a dose of Regeneron Pharmaceuticals Inc.’s experimental neutralizing antibody cocktail, which is currently being tested in clinical trials for non-hospitalized COVID-19 patients.
U.S. stock benchmarks closed lower Friday, as investors reacted to a weaker-than-expected jobs report for September and news that President Donald Trump and first lady Melania tested positive for the coronavirus.
The snags holding up a second big coronavirus economic aid package include money for state and local government as well as for the unemployed, House Speaker Nancy Pelosi told her colleagues Friday.
The record decline in the U.S. economy in the early stages of the coronavirus pandemic was lowered slightly to a 31.4% annual pace — setting the stage for a big rebound in the third quarter.